| Grane Hospice 106 Zee Plaza, Hollidaysburg, PA, 16648 | |
| (814) 695-2793 |
News Archive
Many cells in the inner lining of the uterus carry 'cancer-driving' mutations that frequently arise early in life, report scientists from the Wellcome Sanger Institute, the University of Cambridge and their collaborators.
Cardium Therapeutics today announced the initiation of the ASPIRE Phase 3 registration study to evaluate the therapeutic effects of Cardium's lead product candidate, Generx (Ad5FGF-4) in patients with myocardial ischemia.
A new study has revealed that a commonly and widely used healthcare algorithm may be biased against blacks and may be denying them of vital medical treatment. The study titled, "Dissecting racial bias in an algorithm used to manage the health of populations," was published this week in the latest issue of the journal Science.
The New York Times: "In a study that sheds new light on the effects of end-of-life care, doctors have found that patients with terminal lung cancer who began receiving palliative care immediately upon diagnosis not only were happier, more mobile and in less pain as the end neared — but they also lived nearly three months longer.
An immune system protein could act as an early warning system for lung cancer, reveals research published ahead of print in the journal Thorax.
› Verified 3 days ago
| Name | Grane Hospice |
|---|---|
| Location | 106 Zee Plaza, Hollidaysburg, Pennsylvania |
| Hospice ID | 391693 |
| Category | Part of a Home Health Agency |
| Ownership Type | Proprietary - Corporation |
| Profit Type | FOR PROFIT |
| SSA county code | 120 |
News Archive
Many cells in the inner lining of the uterus carry 'cancer-driving' mutations that frequently arise early in life, report scientists from the Wellcome Sanger Institute, the University of Cambridge and their collaborators.
Cardium Therapeutics today announced the initiation of the ASPIRE Phase 3 registration study to evaluate the therapeutic effects of Cardium's lead product candidate, Generx (Ad5FGF-4) in patients with myocardial ischemia.
A new study has revealed that a commonly and widely used healthcare algorithm may be biased against blacks and may be denying them of vital medical treatment. The study titled, "Dissecting racial bias in an algorithm used to manage the health of populations," was published this week in the latest issue of the journal Science.
The New York Times: "In a study that sheds new light on the effects of end-of-life care, doctors have found that patients with terminal lung cancer who began receiving palliative care immediately upon diagnosis not only were happier, more mobile and in less pain as the end neared — but they also lived nearly three months longer.
An immune system protein could act as an early warning system for lung cancer, reveals research published ahead of print in the journal Thorax.
› Verified 3 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 99.7 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 99.7 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 38.0 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 99.4 | 97.3 |
| Patients who got timely treatment for shortness of breath | 83.8 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 87.4 | 93.3 |
News Archive
Many cells in the inner lining of the uterus carry 'cancer-driving' mutations that frequently arise early in life, report scientists from the Wellcome Sanger Institute, the University of Cambridge and their collaborators.
Cardium Therapeutics today announced the initiation of the ASPIRE Phase 3 registration study to evaluate the therapeutic effects of Cardium's lead product candidate, Generx (Ad5FGF-4) in patients with myocardial ischemia.
A new study has revealed that a commonly and widely used healthcare algorithm may be biased against blacks and may be denying them of vital medical treatment. The study titled, "Dissecting racial bias in an algorithm used to manage the health of populations," was published this week in the latest issue of the journal Science.
The New York Times: "In a study that sheds new light on the effects of end-of-life care, doctors have found that patients with terminal lung cancer who began receiving palliative care immediately upon diagnosis not only were happier, more mobile and in less pain as the end neared — but they also lived nearly three months longer.
An immune system protein could act as an early warning system for lung cancer, reveals research published ahead of print in the journal Thorax.
› Verified 3 days ago
| Home Health Aides | 22 |
| Counselors | 4 |
| Homemakers | 1 |
| Licensed Practical or Vocational Nurses | 3 |
| Medical Social Workers | 4 |
| Physicians | 2 |
| Registered Nurses | 22 |
| Other Personnel | 8 |
| Total Employees | 66 |
|---|
News Archive
Many cells in the inner lining of the uterus carry 'cancer-driving' mutations that frequently arise early in life, report scientists from the Wellcome Sanger Institute, the University of Cambridge and their collaborators.
Cardium Therapeutics today announced the initiation of the ASPIRE Phase 3 registration study to evaluate the therapeutic effects of Cardium's lead product candidate, Generx (Ad5FGF-4) in patients with myocardial ischemia.
A new study has revealed that a commonly and widely used healthcare algorithm may be biased against blacks and may be denying them of vital medical treatment. The study titled, "Dissecting racial bias in an algorithm used to manage the health of populations," was published this week in the latest issue of the journal Science.
The New York Times: "In a study that sheds new light on the effects of end-of-life care, doctors have found that patients with terminal lung cancer who began receiving palliative care immediately upon diagnosis not only were happier, more mobile and in less pain as the end neared — but they also lived nearly three months longer.
An immune system protein could act as an early warning system for lung cancer, reveals research published ahead of print in the journal Thorax.
› Verified 3 days ago
| Others | 4 |
| Total Volunteers | 4 |
|---|
News Archive
Many cells in the inner lining of the uterus carry 'cancer-driving' mutations that frequently arise early in life, report scientists from the Wellcome Sanger Institute, the University of Cambridge and their collaborators.
Cardium Therapeutics today announced the initiation of the ASPIRE Phase 3 registration study to evaluate the therapeutic effects of Cardium's lead product candidate, Generx (Ad5FGF-4) in patients with myocardial ischemia.
A new study has revealed that a commonly and widely used healthcare algorithm may be biased against blacks and may be denying them of vital medical treatment. The study titled, "Dissecting racial bias in an algorithm used to manage the health of populations," was published this week in the latest issue of the journal Science.
The New York Times: "In a study that sheds new light on the effects of end-of-life care, doctors have found that patients with terminal lung cancer who began receiving palliative care immediately upon diagnosis not only were happier, more mobile and in less pain as the end neared — but they also lived nearly three months longer.
An immune system protein could act as an early warning system for lung cancer, reveals research published ahead of print in the journal Thorax.
› Verified 3 days ago
| Grane Hospice Location: 106 Zee Plaza, Hollidaysburg, Pennsylvania, 16648 Phone: (814) 695-2793 |